Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue, net $ 10,373 $ 8,756 $ 28,537 $ 29,504
Cost of revenue 3,193 3,317 9,799 11,418
Gross profit 7,180 5,439 18,738 18,086
Operating expenses:        
Sales and marketing 2,704 2,087 7,088 7,811
Research and development 160 150 461 500
General and administrative 6,716 2,057 12,143 7,268
Total operating expenses 9,580 4,294 19,692 15,579
Operating (loss) income from continuing operations (2,400) 1,145 (954) 2,507
Note payable interest (30) (156)
Other income (expense), net 15 (115) 33 (112)
(Loss) income from continuing operations before tax (2,385) 1,000 (921) 2,239
(Benefit) provision for income taxes (884) (11) (517) 7
(Loss) income from continuing operations (1,501) 1,011 (404) 2,232
Loss from discontinued operations, net of tax (109) (100) (327) (314)
Net (loss) income $ (1,610) $ 911 $ (731) $ 1,918
Basic income (loss) per share of common stock:        
From continuing operations $ (0.26) $ 1.14 $ (0.08) $ 2.52
From discontinued operations (0.02) (0.11) (0.06) (0.35)
Net income (loss) per basic share of common stock (0.28) 1.03 (0.14) 2.17
Diluted income (loss) per share of common stock:        
From continuing operations (0.26) 0.18 (0.08) 0.40
From discontinued operations (0.02) (0.02) (0.06) (0.06)
Net income (loss) per diluted share of common stock $ (0.28) $ 0.16 $ (0.14) $ 0.35
Weighted average number of common shares and common share equivalents outstanding:        
Basic 5,705 885 5,210 885
Diluted 5,705 5,539 5,210 5,539